MGluR5 positive modulators both potentiate activation and restore inhibition in NMDA receptors by PKC dependent pathway

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Chen, Hwei Hsien ^a   Liao, Pei Fei ^a   Chan, Ming Huan ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 HYDROXYPHENYLGLYCINE; 3 CYANO N (1,3 DIPHENYL 1H PYRAZOL 5 YL)BENZAMIDE; 3,3' DIFLUOROBENZALDAZINE; CHELERYTHRINE CHLORIDE; D APV; IFENPRODIL; KETAMINE; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG; 2 AMINO 5 PHOSPHONOVALERIC ACID; METABOTROPIC RECEPTOR; PIPERIDINE DERIVATIVE;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ELECTRIC POTENTIAL; HIPPOCAMPUS; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; MALE; METABOLISM; NUDE MOUSE; SYNAPTIC TRANSMISSION;

MUS;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; HIPPOCAMPUS; KETAMINE; MALE; MICE; MICE, NUDE; PIPERIDINES; PROTEIN KINASE C; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 79951801967     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-19     Document Type: Article

References (35)

1. The metabotropic glutamate receptors: structure and functions. JP Pin R Duvoisin, Neuropharmacology 1995 34 1 1 26 10.1016/0028-3908(94)00129-G 7623957
2. Pharmacology and functions of metabotropic glutamate receptors. PJ Conn JP Pin, Annu Rev Pharmacol Toxicol 1997 37 205 37 10.1146/annurev.pharmtox.37.1. 205 9131252 (Pubitemid 27238875)
3. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. DD Schoepp DE Jane JA Monn, Neuropharmacology 1999 38 10 1431 76 10.1016/S0028-3908(99)00092-1 10530808 (Pubitemid 29457728)
4. Glutamate receptors: brain function and signal transduction. S Nakanishi, et al. Brain Res Brain Res Rev 1998 26 2-3 230 5 10.1016/S0165-0173(97)00033-7 9651535 (Pubitemid 28318078)
5. Group I metabotropic glutamate receptor-mediated calcium signalling and immediate early gene expression in cultured rat striatal neurons. L Mao JQ Wang, Eur J Neurosci 2003 17 4 741 50 10.1046/j.1460-9568.2003.02495.x 12603264 (Pubitemid 36315244)
6. Cross talk between metabotropic and ionotropic glutamate receptor-mediated signaling in parallel fiber-induced inositol 1,4,5-trisphosphate production in cerebellar Purkinje cells. Y Okubo, et al. J Neurosci 2004 24 43 9513 20 10.1523/JNEUROSCI.1829-04.2004 15509738 (Pubitemid 39441505)
7. NMDA-induced phosphorylation and regulation of mGluR5. S Alagarsamy, et al. Pharmacol Biochem Behav 2002 73 2 299 306 10.1016/S0091-3057(02)00826-2 12117583 (Pubitemid 34765568)
8. Interactions between ionotropic and metabotropic glutamate receptors regulate cAMP response element-binding protein phosphorylation in cultured striatal neurons. L Mao JQ Wang, Neuroscience 2002 115 2 395 402 10.1016/S0306-4522(02)00400-1 12421605 (Pubitemid 35284756)
9. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. H Awad, et al. J Neurosci 2000 20 21 7871 9 11050106
10. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. A Pisani, et al. Neuroscience 2001 106 3 579 87 10.1016/S0306-4522(01)00297-4 11591458 (Pubitemid 32925246)
11. The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity. SA Henry, et al. Neuropharmacology 2002 43 8 1199 209 10.1016/S0028-3908(02)00332-5 12527469 (Pubitemid 36084431)
12. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition. M Pietraszek, et al. Neuropharmacology 2005 49 1 73 85 10.1016/j.neuropharm.2005.01.027 15992582 (Pubitemid 40910017)
13. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats. UC Campbell, et al. Psychopharmacology (Berl) 2004 175 3 310 8 10.1007/s00213-004-1827-5 15024550 (Pubitemid 39366025)
14. Ketamine, but not propofol, anaesthesia is regulated by metabotropic glutamate 5 receptors. JH Sou MH Chan HH Chen, Br J Anaesth 2006 96 5 597 601 10.1093/bja/ael046 16531447
15. Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice. MH Chan, et al. Psychopharmacology (Berl) 2008 198 1 141 8 10.1007/s00213-008-1103-1 18311557
16. A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. GG Kinney, et al. J Pharmacol Exp Ther 2005 313 1 199 206 10.1124/jpet.104.079244 15608073 (Pubitemid 40411343)
17. Recent advances in positive allosteric modulators of metabotropic glutamate receptors. WD Shipe, et al. Curr Opin Drug Discov Devel 2005 8 4 449 57 16022181 (Pubitemid 40917406)
18. Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamides that potentiate receptor function in vivo. CW Lindsley, et al. J Med Chem 2004 47 24 5825 8 10.1021/jm049400d 15537338 (Pubitemid 39507327)
19. A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain. JA O'Brien, et al. J Pharmacol Exp Ther 2004 309 2 568 77 14747613 (Pubitemid 38542609)
20. (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. AJ Doherty, et al. Neuropharmacology 1997 36 2 265 7 10.1016/S0028-3908(97)00001-4 9144665 (Pubitemid 27149516)
21. Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects. MT Tebano, et al. J Neurochem 2005 95 4 1188 200 10.1111/j.1471-4159.2005.03455.x 16271052 (Pubitemid 41713501)
22. Interaction of group I mGlu and NMDA receptor agonists within the dorsal horn of the spinal cord of the juvenile rat. K Dang, et al. Br J Pharmacol 2002 136 2 248 54 10.1038/sj.bjp.0704698 12010773 (Pubitemid 34587671)
23. Age-related decline in the functional response of striatal group I mGlu receptors. A Pintor, et al. Neuroreport 2000 11 13 3033 8 10.1097/00001756- 200009110-00041 11006989
24. Group I metabotropic glutamate receptors modulate glutamate and gamma-aminobutyric acid release in the periaqueductal grey of rats. V de Novellis, et al. Eur J Pharmacol 2003 462 1-3 73 81 10.1016/S0014-2999(03)01342- 6 12591098 (Pubitemid 36183737)
25. Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. L Lecourtier, et al. Biol Psychiatry 2007 62 7 739 46 10.1016/j.biopsych.2006.12.003 17511968 (Pubitemid 47374648)
26. Bursting of prefrontal cortex neurons in awake rats is regulated by metabotropic glutamate 5 (mGlu5) receptors: rate-dependent influence and interaction with NMDA receptors. H Homayoun B Moghaddam, Cereb Cortex 2006 16 1 93 105 10.1093/cercor/bhi087 15843630 (Pubitemid 41748285)
27. Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release. H Homayoun, et al. Neuropsychopharmacology 2004 29 7 1259 69 10.1038/sj.npp. 1300417 15010696 (Pubitemid 38780649)
28. NR2B selective NMDA receptor antagonists. SS Nikam LT Meltzer, Curr Pharm Des 2002 8 10 845 55 10.2174/1381612024607072 11945135 (Pubitemid 34506366)
29. NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin. S Alagarsamy, et al. Neuropharmacology 2005 49 Suppl 1 135 45 10.1016/j.neuropharm.2005.05.005 16005030 (Pubitemid 41115900)
30. Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. Z Jia, et al. Learn Mem 1998 5 4-5 331 43 10454358 (Pubitemid 29115263)
31. Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes. P Benquet CE Gee U Gerber, J Neurosci 2002 22 22 9679 86 12427823 (Pubitemid 35332851)
32. Mechanisms involved in the metabotropic glutamate receptor-enhancement of NMDA-mediated motoneurone responses in frog spinal cord. AM Holohean JC Hackman RA Davidoff, Br J Pharmacol 1999 126 1 333 41 10.1038/sj.bjp.0702263 10051153 (Pubitemid 29041775)
33. Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons. A Ugolini M Corsi F Bordi, Neuropharmacology 1999 38 10 1569 76 10.1016/S0028-3908(99)00095-7 10530818 (Pubitemid 29457738)
34. Regulation of phosphorylation of NMDA receptor NR1 subunits in the rat neostriatum by group I metabotropic glutamate receptors in vivo. ES Choe EH Shin JQ Wang, Neurosci Lett 2006 394 3 246 51 10.1016/j.neulet.2005.10.072 16300895 (Pubitemid 43144859)
35. The effect of mGlu5 receptor positive allosteric modulators on signaling molecules in brain slices. F Liu G Zhang G Hornby D Vasylyev, et al. Eur J Pharmacol 2006 536 3 262 8 10.1016/j.ejphar.2006.02.003 16600209